immuno-chemotherapy
Showing 9976 - 10000 of >10,000
Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor
Unknown status
- Solid Tumors
- +4 more
- detection of genotype
-
Beijing, Beijing, China
- +5 more
Aug 27, 2019
Capecitabine-based Chemotherapy Toxicities in Chinese Solid
Unknown status
- Solid Tumor
- +4 more
- detection of genotype
-
Beijing, Beijing, China
- +6 more
Aug 27, 2019
Uterine Cervical Tumor, Cervical Cancer, Uterine Cervical Cancer Trial in Wuhan (NACT, RT+PLND, Adjuvant chemo)
Unknown status
- Uterine Cervical Neoplasm
- +2 more
- NACT
- +2 more
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Feb 1, 2019
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Pesaro (capecitabine, Docetaxel)
Unknown status
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
-
Pesaro, Italy
- +1 more
Feb 26, 2019
Leptomeningeal Metastases Trial in Changchun (Pemetrexed, Dexamethasone, Folic Acid)
Completed
- Leptomeningeal Metastases
- Pemetrexed
- +3 more
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Mar 16, 2019
Successful Conversion Rate of Operation, Unresectable Gastric Cancer Trial in Hangzhou (Arterial catheter infusion chemo, Sodium
Unknown status
- Successful Conversion Rate of Operation
- Unresectable Gastric Cancer
- Arterial catheter infusion chemotherapy
- +3 more
-
Hangzhou, Zhejiang, ChinaThe Second affiliated Hospital, Zhejiang University School of Me
Feb 18, 2019
Liver Cancer, Metastatic Cancer Trial in Chicago (capecitabine, yttrium Y 90 glass microspheres)
Completed
- Liver Cancer
- Metastatic Cancer
- capecitabine
- yttrium Y 90 glass microspheres
-
Chicago, IllinoisNorthwestern University
Sep 5, 2019
Estrogen Receptor Negative, HER2/Neu Negative, Metastatic Breast Cancer Trial in Seattle (Pembrolizumab, Cisplatin)
Withdrawn
- Estrogen Receptor Negative
- +5 more
- Pembrolizumab
- Cisplatin
-
Seattle, WashingtonSeattle Cancer Care Alliance, Fred Hutch/University of Washingto
Apr 24, 2019
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Melbourne (Atezolizumab, Bevacizumab, Cobimetinib)
Recruiting
- Ovarian Cancer
- +2 more
- Atezolizumab
- +2 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Dec 18, 2019
Metastatic Pancreatic Cancer Trial in Scottsdale, Baltimore, Philadelphia (Gemcitabine, nab-Paclitaxel, GDC-0449)
Completed
- Metastatic Pancreatic Cancer
- Gemcitabine, nab-Paclitaxel, GDC-0449
-
Scottsdale, Arizona
- +2 more
Apr 2, 2019
Triple-negative Breast Cancer Trial (Vinorelbine + , Vinorelbine + Apatinib)
Not yet recruiting
- Triple-negative Breast Cancer
- Vinorelbine + placebo
- Vinorelbine + Apatinib
- (no location specified)
Apr 26, 2019
Breast Tumors Trial in Vancouver (Exercise)
Completed
- Breast Neoplasms
- Exercise
-
Vancouver, British Columbia, CanadaBreast Cancer Training Center, 614 W. 8th Ave
Feb 17, 2019
Taxane Acute Pain Syndrome in Patients Receiving Taxane
Completed
- Acute Pain
- Quality of life and brief pain inventory
-
Ottawa, Ontario, CanadaRicardo Fernandes
Sep 3, 2019
Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (Sorafenib, HAIC of FOLFOX, HAIC of OXA)
Unknown status
- Hepatocellular Carcinoma
- Sorafenib
- +2 more
-
Guangzhou, Guangdong, China
- +2 more
Apr 15, 2019
Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia, Relapse Trial run by the NHLBI (Alemtuzumab (Campath ),
Completed
- Severe Aplastic Anemia, Refractory
- Severe Aplastic Anemia, Relapse
- Alemtuzumab (Campath )
- Cyclosporine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2020
Gene Expression in Pancreatic Cancer
Terminated
- Pancreatic Cancer
- Endoscopic Ultrasound
- Pancreaticoduodenectomy
-
Oxford, United KingdomOxford University Hospitals NHS Foundation Trust
Mar 23, 2020
Stroke, CVA, Hemiplegia Trial in Frisco (Posterior Leaf spring AFO, Double adjustable AFO)
Completed
- Stroke
- +4 more
- Posterior Leaf spring AFO
- Double adjustable AFO
-
Frisco, TexasBaylor Institute for rehabilitation
Feb 14, 2020
Colorectal Cancer Metastatic, Chemo Effect, Chemotherapeutic Toxicity Trial in Nanjing (Irinotecan, Oxaliplatin, Capecitabine)
Unknown status
- Colorectal Cancer Metastatic
- +2 more
- Irinotecan
- +2 more
-
Nanjing, Jiangsu, ChinaThe Comprehensive Cancer Center of Nanjing Drum Tower Hospital
Jan 1, 2019
Breast Tumors, Endothelial Dysfunction, Cardiovascular Disease Trial in Aarhus (Venous occlusion plethysmography, SphygmoCor,
Completed
- Breast Neoplasms
- +3 more
- Venous occlusion plethysmography
- +4 more
-
Aarhus, Jutland, DenmarkAarhus University Hospital
Oct 8, 2019
Cognitive Impairment Trial in Pomona (Meditative Movement)
Unknown status
- Cognitive Impairment
- Meditative Movement
-
Pomona, CaliforniaRobert and Beverly Lewis Family Cancer Care Center
Dec 27, 2019
Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Tumor Trial
Completed
- Chronic Myelomonocytic Leukemia
- +5 more
- Cytarabine
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Aug 15, 2019
Glioma, Malignant, Gliosarcoma, Astrocytoma of Brain Trial in Banja Luka, Plovdiv,, Tbilisi (Intranasal Modified Temozolomide)
Unknown status
- Glioma, Malignant
- +2 more
- Intranasal Modified Temozolomide
-
Banja Luka, Bosnia and Herzegovina
- +2 more
Sep 14, 2019
Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)
Completed
- Anaplastic Astrocytoma
- +12 more
- 3-Dimensional Conformal Radiation Therapy
- +5 more
-
Los Angeles, California
- +11 more
Jul 17, 2019